Mortality benefits of influenza vaccination in elderly people.
Thijs
Carel
C
Beyer
Walter E P
WE
Govaert
Phile M E
PM
Sprenger
Marc J W
MJ
Dinant
Geert-Jan
GJ
Knottnerus
André
A
D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D017589:Immunization Programs; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D053122:Influenza A Virus, H3N2 Subtype / Q000276:immunology; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000453:epidemiology / Q000401:mortality* / Q000517:prevention & control*; D008875:Middle Aged; D009026:Mortality; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
D007252:Influenza Vaccines